 |
|
|
| |
Safety and Viral Kinetics of Analytical Treatment Interruption in PWH in a Large Phase 2 Global RCT
|
| |
| |
CROI 2026 Feb 22-25 Denver
Nkosiphile Ndlovu,1 Kimberly Pringle,2 Robert Bolan,3 Charlotte Rolle,4 Javier Morales-Ramirez,5 Jeff Berry,6 Craig Dietz,7 Julie Fox,8 Zachary Baldwin,2 Sarah Gill,2 Arlene Nugent,2 Andrew Topp,2
Ana Gabriela Pires dos Santos,2 Karine Dubé9
1Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; 2AbbVie Inc., North Chicago, IL, USA; 3Los Angeles LGBT Center, Los Angeles, CA, USA; 4Orlando Immunology Center, Orlando, FL, USA; 5Clinical Research Puerto Rico, San Juan, Puerto Rico; 6CRISPR for Cure Martin Delaney Collaboratory Community Advisory Board, Philadelphia, PA, USA; 7KC CARE Health Center, Kansas City, MO, USA;
8Department of Infectious Diseases, Faculty of Medicine, Kings College London, London, UK; 9Division of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego, CA, USA
|
| |
|
|
|
|
|
